Atopic Dermatitis
Atopic dermatitis, commonly known as eczema, is a chronic skin condition characterized by dry, itchy, and inflamed skin. It often appears in childhood and can lead to significant discomfort and skin infections.
Atopic Dermatitis: PF-07275315 and PF-07264660
We are investigating two new treatments for adults with moderate to severe atopic dermatitis. The study aims to see if they are more effective than a placebo in reducing eczema symptoms.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Do you have chronic atopic dermatitis (eczema) that has lasted for at least 6 months?
- Do you have any significant autoimmune diseases like lupus, type 1 diabetes, or multiple sclerosis?
- Are you currently taking any medications for atopic dermatitis like corticosteroids or other immunosuppressants?
- Have you had any significant allergic reactions, including anaphylaxis, to medications or treatments?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Thermalsole und Schwefelbad Bentheim GmbH
Dermatology
Bad Bentheim, Germany
Magdeburger Company For Medical Studies & Services GmbH
Dermacare
Magdeburg, Germany
BAG Dres. med. Quist PartG
Dermatologie
Mainz, Germany
Sponsor: Pfizer Inc.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.